Skip to content
Menu

Lisata Therapeutics, Inc. LSTA

Full chart Compare
Set alert

Price alert · LSTA

All alert types
1.21 USD -0.07 (-5.47%)

Regular-session close

1.15 -0.06 -4.96%

After hours · Nov 13, 4:00 PM ET

1.20 Day range 1.26
0.96 52-week range 5.07
YTD
-34.95%
1 year
-41.55%

Revenue & Expenses

Other Income → Expenses: $661.00KOther Operating Income → Expenses: $146.00KExpenses → Selling, General & Admin: $10.43MExpenses → Research & Development: $7.95MIncome Tax Benefit → Expenses: $962.00KGross Profit → Expenses: $24.00KRevenue → Gross Profit: $24.00KRevenue → Cost of Revenue: $146.00KNet Loss → Expenses: $16.59MOther Income$661.00KOther Operating Income$146.00KIncome Tax Benefit$962.00KGross Profit$24.00KNet Loss$16.59MCost of Revenue$146.00KExpenses$18.38MSelling, General & Admin$10.43MResearch & Development$7.95MRevenue$170.00K

Latest period ending Dec 31, 2025 · select a line to chart its full history

LSTA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
170.00K1.00M000
170.00K1.00M000
-18.21M-22.41M-25.71M-57.60M-29.05M
-16.59M-19.98M-20.84M-54.23M-27.47M
-1.91-2.40-2.58-10.47-7.45
LSTA annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
15.96M16.21M22.59M32.15M24.65M
17.74M35.00M54.69M73.03M97.01M
3.14M5.68M6.80M6.71M5.01M
14.86M29.57M48.15M66.58M92.25M
LSTA annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-15.95M-19.36M-20.03M-21.17M-22.25M
15.09M13.23M10.10M28.91M-54.90M
599.00K-206.00K385.00K-224.00K85.28M
-28.00K00-285.00K-60.00K
-253.00K-6.38M-9.56M7.51M8.13M